Your browser doesn't support javascript.
loading
Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer.
He, Kewen; Zhang, Shaotong; Pang, Jiaohui; Yin, Jiani C; Mu, Dianbin; Wang, Jun; Ge, Hong; Ma, Jie; Yang, Zhe; Zheng, Xiaoli; Dong, Lihua; Zhang, Junli; Chang, Pengyu; Li, Li; Tang, Shanshan; Bao, Hua; Wu, Xue; Wang, Xiaonan; Shao, Yang; Yu, Jinming; Yuan, Shuanghu.
Afiliação
  • He K; Department of Radiation Oncology, Shandong University Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Zhang S; Department of Ultrasound, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Pang J; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Yin JC; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Mu D; Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Wang J; Department of Radiation Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Ge H; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Ma J; Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Yang Z; Department of Radiation Oncology, Shandong Provincial Hospital, Jinan, China.
  • Zheng X; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Dong L; Department of Radiation Oncology & Therapy, Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Jilin, China.
  • Zhang J; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Chang P; Department of Radiation Oncology & Therapy, Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Jilin, China.
  • Li L; Department of Radiation Oncology, Shandong University Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Tang S; Department of Radiation Oncology, Shandong University Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Bao H; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Wu X; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Wang X; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Shao Y; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.
  • Yu J; School of Public Health, Nanjing Medical University, Nanjing, China.
  • Yuan S; Department of Radiation Oncology, Shandong University Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Front Oncol ; 12: 928605, 2022.
Article em En | MEDLINE | ID: mdl-35912186
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China